182 related articles for article (PubMed ID: 17950955)
1. Synthesis and in vitro biological evaluation of valine-containing prodrugs derived from clinically used HIV-protease inhibitors.
Roche D; Greiner J; Aubertin AM; Vierling P
Eur J Med Chem; 2008 Jul; 43(7):1506-18. PubMed ID: 17950955
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro biological evaluation of mannose-containing prodrugs derived from clinically used HIV-protease inhibitors with improved transepithelial transport.
Roche D; Greiner J; Aubertin AM; Vierling P
Bioconjug Chem; 2006; 17(6):1568-81. PubMed ID: 17105238
[TBL] [Abstract][Full Text] [Related]
3. Prodrugs of HIV protease inhibitors-saquinavir, indinavir and nelfinavir-derived from diglycerides or amino acids: synthesis, stability and anti-HIV activity.
Gaucher B; Rouquayrol M; Roche D; Greiner J; Aubertin AM; Vierling P
Org Biomol Chem; 2004 Feb; 2(3):345-57. PubMed ID: 14747863
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of poly(ethylene glycol)-based saquinavir prodrug conjugates and assessment of release and anti-HIV-1 bioactivity using a novel protease inhibition assay.
Gunaseelan S; Debrah O; Wan L; Leibowitz MJ; Rabson AB; Stein S; Sinko PJ
Bioconjug Chem; 2004; 15(6):1322-33. PubMed ID: 15546199
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anti-HIV activity of glucose-containing prodrugs derived from saquinavir, indinavir and nelfinavir.
Rouquayrol M; Gaucher B; Greiner J; Aubertin AM; Vierling P; Guedj R
Carbohydr Res; 2001 Nov; 336(3):161-80. PubMed ID: 11705466
[TBL] [Abstract][Full Text] [Related]
6. Transepithelial transport of prodrugs of the HIV protease inhibitors saquinavir, indinavir, and nelfinavir across Caco-2 cell monolayers.
Rouquayrol M; Gaucher B; Roche D; Greiner J; Vierling P
Pharm Res; 2002 Nov; 19(11):1704-12. PubMed ID: 12458677
[TBL] [Abstract][Full Text] [Related]
7. Dipeptide derivatives of AZT: synthesis, chemical stability, activation in human plasma, hPEPT1 affinity, and antiviral activity.
Santos C; Morais J; Gouveia L; de Clercq E; Pannecouque C; Nielsen CU; Steffansen B; Moreira R; Gomes P
ChemMedChem; 2008 Jun; 3(6):970-8. PubMed ID: 18389514
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anti-HIV activity of prodrugs derived from saquinavir and indinavir.
Farèse-Di Giorgio A; Rouquayrol M; Greiner J; Aubertin AM; Vierling P; Guedj R
Antivir Chem Chemother; 2000 Mar; 11(2):97-110. PubMed ID: 10819434
[TBL] [Abstract][Full Text] [Related]
9. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage.
Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y
J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064
[TBL] [Abstract][Full Text] [Related]
10. Evasion of P-gp mediated cellular efflux and permeability enhancement of HIV-protease inhibitor saquinavir by prodrug modification.
Jain R; Agarwal S; Majumdar S; Zhu X; Pal D; Mitra AK
Int J Pharm; 2005 Oct; 303(1-2):8-19. PubMed ID: 16137847
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and assessment of first-generation polyamidoamine dendrimer prodrugs to enhance the cellular permeability of P-gp substrates.
Najlah M; Freeman S; Attwood D; D'Emanuele A
Bioconjug Chem; 2007; 18(3):937-46. PubMed ID: 17355118
[TBL] [Abstract][Full Text] [Related]
12. Stereoselective evasion of P-glycoprotein, cytochrome P450 3A, and hydrolases by peptide prodrug modification of saquinavir.
Wang Z; Pal D; Mitra AK
J Pharm Sci; 2012 Sep; 101(9):3199-213. PubMed ID: 22611042
[TBL] [Abstract][Full Text] [Related]
13. Effects of human immunodeficiency virus protease inhibitors on the intestinal absorption of tenofovir disoproxil fumarate in vitro.
Tong L; Phan TK; Robinson KL; Babusis D; Strab R; Bhoopathy S; Hidalgo IJ; Rhodes GR; Ray AS
Antimicrob Agents Chemother; 2007 Oct; 51(10):3498-504. PubMed ID: 17664327
[TBL] [Abstract][Full Text] [Related]
14. Interaction of dipeptide prodrugs of saquinavir with multidrug resistance protein-2 (MRP-2): evasion of MRP-2 mediated efflux.
Jain R; Agarwal S; Mandava NK; Sheng Y; Mitra AK
Int J Pharm; 2008 Oct; 362(1-2):44-51. PubMed ID: 18620036
[TBL] [Abstract][Full Text] [Related]
15. The HIV protease inhibitors saquinavir, ritonavir, and nelfinavir induce apoptosis and decrease barrier function in human intestinal epithelial cells.
Bode H; Lenzner L; Kraemer OH; Kroesen AJ; Bendfeldt K; Schulzke JD; Fromm M; Stoltenburg-Didinger G; Zeitz M; Ullrich R
Antivir Ther; 2005; 10(5):645-55. PubMed ID: 16152758
[TBL] [Abstract][Full Text] [Related]
16. Phosphoramidate and phosphate prodrugs of (-)-beta-D-(2R,4R)-dioxolane-thymine: synthesis, anti-HIV activity and stability studies.
Liang Y; Narayanasamy J; Schinazi RF; Chu CK
Bioorg Med Chem; 2006 Apr; 14(7):2178-89. PubMed ID: 16314108
[TBL] [Abstract][Full Text] [Related]
17. Absorption of poorly water soluble drugs subject to apical efflux using phospholipids as solubilizers in the Caco-2 cell model.
Kapitza SB; Michel BR; van Hoogevest P; Leigh ML; Imanidis G
Eur J Pharm Biopharm; 2007 Apr; 66(1):146-58. PubMed ID: 17071065
[TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of dendrimer prodrugs for oral drug delivery.
Najlah M; Freeman S; Attwood D; D'Emanuele A
Int J Pharm; 2007 May; 336(1):183-90. PubMed ID: 17188439
[TBL] [Abstract][Full Text] [Related]
19. In vitro behavior of a phosphate ester prodrug of amprenavir in human intestinal fluids and in the Caco-2 system: illustration of intraluminal supersaturation.
Brouwers J; Tack J; Augustijns P
Int J Pharm; 2007 May; 336(2):302-9. PubMed ID: 17207947
[TBL] [Abstract][Full Text] [Related]
20. Enhanced cellular uptake of Ara-C via a peptidomimetic prodrug, L-valyl-ara-C in Caco-2 cells.
Cheon EP; Hong JH; Han HK
J Pharm Pharmacol; 2006 Jul; 58(7):927-32. PubMed ID: 16805952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
